Literature DB >> 20980559

Screening for Acinetobacter baumannii colonization by use of sponges.

Yohei Doi1, Ezenwa O Onuoha, Jennifer M Adams-Haduch, Diana L Pakstis, Traci L McGaha, Carly A Werner, Bridget N Parker, Maria M Brooks, Kathleen A Shutt, Anthony W Pasculle, Carlene A Muto, Lee H Harrison.   

Abstract

There is currently no consensus method for the active screening of Acinetobacter baumannii. The use of swabs to culture nostrils, pharynx, and skin surface of various anatomical sites is known to yield less-than-optimal sensitivity. In the present study, we sought to determine whether the use of sterile sponges to sample large areas of the skin would improve the sensitivity of the detection of A. baumannii colonization. Forty-six patients known to be colonized with A. baumannii, defined by a positive clinical culture for this organism as defined by resistance to more than two classes of antimicrobials, participated in the study. The screening sites included the forehead, nostrils, buccal mucosa, axilla, antecubital fossa, groin, and toe webs with separate rayon swabs and the forehead, upper arm, and thigh with separate sponges. Modified Leeds Acinetobacter medium (mLAM) agar plates that contained vancomycin and either aztreonam or ceftazidime were used as the selective medium. An enrichment culture grown overnight substantially increased the sensitivity for most sites. The sensitivity ranged between 69.6 and 82.6% for individual sponge sites and 21.7 to 52.2% for individual swab sites when mLAM plates with ceftazidime were inoculated after a 24-h enrichment period. The sponge and swab sites with the best sensitivity were the leg and the buccal mucosa, respectively (82.6% and 52.2%; P = 0.003). The combined sensitivity for the upper arm and leg with a sponge was 89.1%. The novel screening method using sterile sponges was easy to perform and achieved excellent sensitivity for the detection of A. baumannii colonization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20980559      PMCID: PMC3020416          DOI: 10.1128/JCM.01043-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Skin carriage of acinetobacters in Hong Kong.

Authors:  Y W Chu; C M Leung; E T Houang; K C Ng; C B Leung; H Y Leung; A F Cheng
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

2.  Multidrug resistance among gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006-2008.

Authors:  Alexander J Kallen; Alicia I Hidron; Jean Patel; Arjun Srinivasan
Journal:  Infect Control Hosp Epidemiol       Date:  2010-05       Impact factor: 3.254

Review 3.  The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species.

Authors:  David L Paterson
Journal:  Clin Infect Dis       Date:  2006-09-01       Impact factor: 9.079

4.  Skin sampling-validation of a pad method and comparison with commonly used methods.

Authors:  A Hambraeus; J Hoborn; W Whyte
Journal:  J Hosp Infect       Date:  1990-07       Impact factor: 3.926

5.  Acinetobacter skin colonization of US Army Soldiers.

Authors:  Matthew E Griffith; Julia M Ceremuga; Michael W Ellis; Charles H Guymon; Duane R Hospenthal; Clinton K Murray
Journal:  Infect Control Hosp Epidemiol       Date:  2006-06-12       Impact factor: 3.254

6.  Distribution of Acinetobacter species on skin of healthy humans.

Authors:  J Berlau; H Aucken; H Malnick; T Pitt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-03       Impact factor: 3.267

7.  Description of Leeds Acinetobacter Medium, a new selective and differential medium for isolation of clinically important Acinetobacter spp., and comparison with Herellea agar and Holton's agar.

Authors:  A Jawad; P M Hawkey; J Heritage; A M Snelling
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

8.  Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods.

Authors:  H Seifert; L Dijkshoorn; P Gerner-Smidt; N Pelzer; I Tjernberg; M Vaneechoutte
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

9.  Economic impact of Acinetobacter baumannii infection in the intensive care unit.

Authors:  Bruce Y Lee; Sarah M McGlone; Yohei Doi; Rachel R Bailey; Lee H Harrison
Journal:  Infect Control Hosp Epidemiol       Date:  2010-10       Impact factor: 3.254

10.  Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii.

Authors:  Dror Marchaim; Shiri Navon-Venezia; David Schwartz; Jalal Tarabeia; Iris Fefer; Mitchell J Schwaber; Yehuda Carmeli
Journal:  J Clin Microbiol       Date:  2007-02-21       Impact factor: 5.948

View more
  12 in total

1.  Laboratory evaluation of the ESwab transport system for the recovery of carbapenem-resistant Acinetobacter baumannii.

Authors:  J Moran-Gilad; D Schwartz; S Navon-Venezia; Y Carmeli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-09       Impact factor: 3.267

Review 2.  Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options.

Authors:  Yohei Doi; Gerald L Murray; Anton Y Peleg
Journal:  Semin Respir Crit Care Med       Date:  2015-02-02       Impact factor: 3.119

3.  Screening for methicillin-resistant Staphylococcus aureus colonization using sponges.

Authors:  Chang-Seop Lee; Bianca Montalmont; Jessica A O'Hara; Alveena Syed; Charma Chaussard; Traci L McGaha; Diana L Pakstis; Ju-Hyung Lee; Kathleen A Shutt; Yohei Doi
Journal:  Infect Control Hosp Epidemiol       Date:  2015-01       Impact factor: 3.254

4.  Economic value of Acinetobacter baumannii screening in the intensive care unit.

Authors:  B Y Lee; S M McGlone; Y Doi; R R Bailey; L H Harrison
Journal:  Clin Microbiol Infect       Date:  2011-04-04       Impact factor: 8.067

5.  Natural history of multidrug-resistant Acinetobacter baumannii carriage in intensive care units.

Authors:  Yohei Doi; Sheena Kandiah; Rahman S Hariri; Lee H Harrison
Journal:  Infect Control Hosp Epidemiol       Date:  2012-04-13       Impact factor: 3.254

6.  Characterising the Transmission Dynamics of Acinetobacter baumannii in Intensive Care Units Using Hidden Markov Models.

Authors:  Tan N Doan; David C M Kong; Caroline Marshall; Carl M J Kirkpatrick; Emma S McBryde
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

7.  Infection control management and surveillance of carbapenem-resistant Gram-negative bacteria in hematopoietic stem cell recipients.

Authors:  Claas Baier; Maleen Beck; Viktoria Panagiota; Catherina Lueck; Daniel Kharazipour; Sophie Charlotte Hintze; Robin Bollin; Ella Ebadi; Stefan Ziesing; Matthias Eder; Franz-Christoph Bange; Gernot Beutel
Journal:  Antimicrob Resist Infect Control       Date:  2019-10-21       Impact factor: 4.887

8.  Infection control response to an outbreak of OXA-23 carbapenemase-producing carbapenem-resistant Acinetobacter baumannii in a skilled nursing facility in Utah.

Authors:  Amanda R Smith; Maureen Vowles; Roberta Z Horth; Lori Smith; Linda Rider; Jennifer M Wagner; Anna Sangster; Erin L Young; Hailey Schuckel; James Stewart; Randon J Gruninger; Alessandro Rossi; Kelly F Oakeson; Allyn K Nakashima
Journal:  Am J Infect Control       Date:  2020-11-17       Impact factor: 2.918

9.  Characteristics of multidrug-resistant Acinetobacter baumannii strains isolated in Geneva during colonization or infection.

Authors:  Abdessalam Cherkaoui; Stéphane Emonet; Gesuele Renzi; Jacques Schrenzel
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-09-11       Impact factor: 3.944

10.  Treatment for patients with multidrug resistant Acinetobacter baumannii pulmonary infection.

Authors:  Tao Pan; Xiaoyun Liu; Shougui Xiang; Wenli Ji
Journal:  Exp Ther Med       Date:  2016-02-08       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.